Medicare

Commentary

After Midterms, Democrats Inch Toward Government-Run Health Care

The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Commentary

Medicare for All Lost Big Time in the Midterms

Democrats won big during the midterm elections earlier this month. As of this writing, they appear to have picked up 39 seats in the House of Representatives. But Medicare for All — the rallying cry for much of the far left — lost big time. Voters outside liberal enclaves rejected ...
Commentary

Florida voters rejected Medicare for All in the midterms. Thank goodness.

This month, Democrats took the House of Representatives. But many of the party’s most progressive candidates outside deep-blue coastal enclaves fell short at the polls. Voters in Nebraska, Wisconsin, Pennsylvania, Kansas, Florida, and Maryland all rejected Democratic candidates who campaigned on Medicare for All. And thank goodness. The idea polled ...
Commentary

Voters Swallowed The Medicaid Snake Oil

Voters in Idaho, Nebraska, and Utah just approved ballot referendums to expand Medicaid. The three solidly red states will soon add 300,000 beneficiaries to the joint state-federal insurance program for low-income Americans. These voters doubtless had good intentions. They wanted to help vulnerable residents in their states gain access to health ...
Business & Economics

The Bizarre World of Drug Pricing

There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Business & Economics

New Medicare Price Controls Don’t Put America First

Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
Drug Pricing

Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times

‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Commentary

At the VA, bureaucrats — not doctors — hold the scalpel

Staff at nine Veterans Affairs hospitals recently canceled more than 250,000 orders for diagnostic tests. They thought the orders were duplicative or unnecessary. In many cases, they were mistaken. As a result, veterans went without needed CT scans, ultrasounds, and other potentially lifesaving tests, according to a USA Today investigation. ...
Blog

Free-Markets 101: Politicians Need a Good Education About Running a Business

There are not enough politicians who know what it takes to run a business. Many argue that government would improve if it was run more like a business. Having been an entrepreneur and business owner, I know firsthand the blessings and challenges that come with owning a business. And having ...
Commentary

After Midterms, Democrats Inch Toward Government-Run Health Care

The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Commentary

Medicare for All Lost Big Time in the Midterms

Democrats won big during the midterm elections earlier this month. As of this writing, they appear to have picked up 39 seats in the House of Representatives. But Medicare for All — the rallying cry for much of the far left — lost big time. Voters outside liberal enclaves rejected ...
Commentary

Florida voters rejected Medicare for All in the midterms. Thank goodness.

This month, Democrats took the House of Representatives. But many of the party’s most progressive candidates outside deep-blue coastal enclaves fell short at the polls. Voters in Nebraska, Wisconsin, Pennsylvania, Kansas, Florida, and Maryland all rejected Democratic candidates who campaigned on Medicare for All. And thank goodness. The idea polled ...
Commentary

Voters Swallowed The Medicaid Snake Oil

Voters in Idaho, Nebraska, and Utah just approved ballot referendums to expand Medicaid. The three solidly red states will soon add 300,000 beneficiaries to the joint state-federal insurance program for low-income Americans. These voters doubtless had good intentions. They wanted to help vulnerable residents in their states gain access to health ...
Business & Economics

The Bizarre World of Drug Pricing

There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Business & Economics

New Medicare Price Controls Don’t Put America First

Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
Drug Pricing

Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times

‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Commentary

At the VA, bureaucrats — not doctors — hold the scalpel

Staff at nine Veterans Affairs hospitals recently canceled more than 250,000 orders for diagnostic tests. They thought the orders were duplicative or unnecessary. In many cases, they were mistaken. As a result, veterans went without needed CT scans, ultrasounds, and other potentially lifesaving tests, according to a USA Today investigation. ...
Blog

Free-Markets 101: Politicians Need a Good Education About Running a Business

There are not enough politicians who know what it takes to run a business. Many argue that government would improve if it was run more like a business. Having been an entrepreneur and business owner, I know firsthand the blessings and challenges that come with owning a business. And having ...
Scroll to Top